(Q73895210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Jantunen E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kuittinen T

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Nousiainen T

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

569-573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953128%20AND%20SRC:MED&resulttype=core&format=json

Hematopoietic stem cell transplantation activity in Europe 1999

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

Broad inter‐individual variations in circulating progenitor cell numbers induced by granulocyte colony‐stimulating factor therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021

The whys and hows of hematopoietic progenitor and stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704184

7 January 2021